BSE filing, BSE: 543931. Summary written from the filing by ALFA Finder's alert engine.
Veefin Solutions Ltd: key numbers
- Share price
- ₹233.45
- Market cap
- ₹596.2 Cr
- Revenue (annual)
- ₹345.1 Cr
- Net profit (annual)
- ₹22.78 Cr
- P/E (TTM)
- 26.2×Sector 22.9×
- Promoter holding
- 34.73%+0.00% QoQ
- FII holding
- 2.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Veefin Solutions Ltd
All →Veefin Solutions Results Update
Veefin reported H1 FY27 revenue of ₹238.82 Cr (up 116% YoY) and PAT of ₹24.85 Cr. The company highlighted a ₹920 Cr opportunity pipeline in banking technology.
Veefin Solutions Investor Presentation: Key Takeaways
H1 FY27 group revenue ₹238.82 cr (+116.2% YoY), PAT ₹24.85 cr (+126.6%), EBITDA margin 25.5%. Standalone Q2 PAT flat; ₹920 cr pipeline, 84% outside India.
Veefin Solutions Q2 FY27 Results: Net Profit ₹15.3 Cr, Up 61.1% QoQ
Veefin Solutions Ltd reported revenue from operations of ₹124.7 Cr and net profit of ₹15.3 Cr for Q2 FY27.
- Key figure
- Net profit ₹15.3 Cr
Veefin Solutions Acquisition
Veefin Solutions disclosed its step-down subsidiaries' board-approved amalgamation, NTPL into WRM, via a Companies Act scheme. Consideration is share-based, with no cash paid.
Veefin Solutions Other Announcement
Veefin Solutions Ltd has filed its quarterly shareholding pattern as per SEBI Regulation 31. This is a routine regulatory compliance disclosure.
Veefin Solutions Board Meeting Date
Veefin Solutions has scheduled a Board meeting on October 26, 2026 to consider Q1 and H1 FY27 results. The trading window remains closed pending results declaration.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date